FINWIRES · TerminalLIVE
FINWIRES

Northrop Grumman Remains Well-Positioned Across Strategic Programs and Defense Portfolios, RBC Says

-- Northrop Grumman (NOC) remains well-positioned across strategic programs and its broader weapons and missile defense portfolios, despite the uncertainty over free cash flow in 2027 and 2028 weighing on the stock, RBC Capital Markets said in a note Wednesday.

The analysts noted that the commentary on the B-21 and Sentinel programs was positive. The Sentinel program is on track for low-double-digit growth this year as it moves towards first flight in 2027, the brokerage highlighted.

RBC added that Northrop has pulled back its earlier 2027-2028 FCF guide, as it sees an incremental $2.5 billion in investments to support the B-21 ramp, which weighed on the stock.

Northrop continues to guide to 2026 sales of $43.5 billion to $44 billion and FCF of $3.1 billion to $3.5 billion. RBC revised its revenue estimate slightly to $44.1 billion and maintained its FCF estimate of $3.3 billion.

RBC maintained an outperform rating on Northrop Grumman with a price target of $750.

Price: $591.55, Change: $-19.58, Percent Change: -3.20%

Related Articles

Australia

Lucid Diagnostics Completes $18 Million Direct Offering of Shares

Lucid Diagnostics (LUCD) said Friday that is has completed its underwritten direct offering of 18 million shares at $1 per share.The company said the offering was anchored by a $15 million investment from a "fundamental" institutional investor with support from a large existing shareholder.Lucid said it plans to use the net proceeds for working capital and general corporate purposes.Price: $1.09, Change: $-0.01, Percent Change: -0.46%

$LUCD
Australia

Dover Sees Strong Bookings Growth, Demand Momentum, RBC Capital Markets Says

Dover (DOV) reported a modest Q1 operating beat, with 24% bookings growth and a 1.20x book-to-bill ratio pointing to demand momentum, RBC Capital Markets said in a Thursday note.The firm said bookings strength was broad-based, with all segments posting book-to-bill above 1.10x.RBC highlighted strength in clean energy components, fluid transport, retail fueling, refrigerated door cases, heat exchangers and CO2 refrigeration systems.The firm also said bookings strength suggests upside to Dover's 3% to 5% organic growth guidance. Dover reaffirmed its 2026 adjusted earnings per share guidance of $10.45 to $10.65, and revenue growth outlook of 5% to 7%.RBC raised its price target to $252 from $225, and maintained its sector perform rating on Dover.Price: $229.96, Change: $+1.81, Percent Change: +0.79%

$DOV
Insider Trading

Pharvaris Insider Sold Shares Worth $441,726, According to a Recent SEC Filing

Anne Lesage, Chief Early Development Officer, on April 22, 2026, sold 14,700 shares in Pharvaris (PHVS) for $441,726. Following the Form 4 filing with the SEC, Lesage has control over a total of 213,319 common shares of the company, with 56,450 shares held directly and 156,869 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1830487/000119312526176222/xslF345X05/ownership.xmlPrice: $28.49, Change: $+1.20, Percent Change: +4.40%

$PHVS